Research Use Only · Third-Party Testing Available · COA Documentation · Premium Laboratory Catalog

HomeResearch CatalogGLP-1 / Metaboliccagrilintide 5mg+Semaglutide 5mg
cagrilintide 5mg+Semaglutide 5mg
Research Use OnlyIn Stock

Certificate of Analysis

Purity

≥98.0%

Method

HPLC / MS

Testing

Third-Party

COA Status

Available

GLP-1 / MetabolicGLP-1 Research

cagrilintide 5mg+Semaglutide 5mg

A research compound studied in laboratory models involving incretin-related signaling, metabolic pathway investigation, and compound characterization.

Choose Pack Size

$80.001 Vial

Quantity

1
Total: $80.00
Third-Party Tested
COA Available
Fast Fulfillment
Research Grade

Research Use Only — All products are intended strictly for laboratory research purposes and are not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.

About cagrilintide 5mg+Semaglutide 5mg

This high-concentration research formulation combines cagrilintide (5 mg) and semaglutide (5 mg) in a single lyophilized vial, providing double the peptide mass per vial relative to the 2.5 mg variant. Cagrilintide (AM833; CAS 2190688-95-6) is a long-acting synthetic amylin analog designed to engage amylin receptor subtypes (AMY1-R through AMY3-R) with extended pharmacokinetic stability, while semaglutide (NNC-0177-0864; CAS 910463-68-2) is a 34-amino acid GLP-1 receptor agonist with C18 fatty-diacid albumin-binding modification.

In laboratory research contexts, this dual-component formulation supports the investigation of coordinated amylin receptor and GLP-1 receptor signaling dynamics, concentration-response studies requiring higher compound loads in assay systems, and comparative pharmacological profiling of simultaneous amylinergic and incretin receptor pathway activation. Both compounds are provided in lyophilized form for stability, and the formulation is intended strictly for in vitro and preclinical research by qualified investigators.

Formulation Information

PropertyValue
Molecular FormulaMulti-component blend
Molecular WeightCagrilintide: ~3,907.4 g/mol | Semaglutide: 4,113.6 g/mol
CAS NumberN/A — Research Blend
SynonymsCagriSema 5mg (research reference), High-Dose Amylin/GLP-1 Research Blend
LABVERIFIED

99%+

PURITY

Third Party Tested

Independently verified by ISO-accredited laboratories. Batch-specific COAs available on request.

GOOD MANUFACTURINGPRACTICE

GMP

CERT.

GMP Manufacturing Standards

Synthesized in registered facilities following Good Manufacturing Practices with full chain-of-custody documentation.

FASTSHIPPING

FAST

SHIP

Best in Class Fulfillment

Same-day fulfillment on qualifying orders. Secure cold-chain packaging. Domestic and international research shipping.

NOPRESERVATIVE

ZERO

FILLERS

Zero Fillers or Additives

Pure active compounds only. Lyophilized without fillers or preservatives. Composition independently verified.

Scientific Content Review

All technical product descriptions, molecular data, and research context on this page have been prepared with reference to published scientific literature and PubChem compound databases. Content is intended for informational purposes in a research catalog context and does not constitute medical advice or claim therapeutic efficacy.

cagrilintide 5mg+Semaglutide 5mg is a research compound available for controlled laboratory investigation and scientific study. This product is intended strictly for in vitro research, preclinical investigation, and analytical characterization by qualified researchers. Not for human consumption.

Category

GLP-1 / Metabolic

Purity

≥98.0%

Available Sizes

10MG

COA

Available

Research Cart

Research use only — not for human consumption

Your research cart is empty